Aryogen Biopharma

AryoGen Biopharma is a leading biotechnology company based in Iran, specializing in the development and large-scale manufacture of biosimilar therapeutic proteins and monoclonal antibodies. Established in 2009 and operating as a key member of the CinnaGen Group, the company maintains one of the most advanced biopharmaceutical facilities in the Middle East and North Africa (MENA) region. Its portfolio includes high-value biologics for oncology, hematology, and autoimmune disorders, such as biosimilars for rituximab, trastuzumab, and recombinant factor VIIa. AryoGen is recognized for its adherence to international Good Manufacturing Practice (GMP) standards and its commitment to providing affordable access to complex biological therapies in emerging markets. The company also offers contract manufacturing services, leveraging its expertise in mammalian cell culture and protein purification.